Home / Resource Library / The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma

The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma

Article discusses CAR-T versus bispecifics for treatment of relapsed DLBCL.